05/24/2019
Former FDA Commissioner Scott Gottlieb has been named a special partner at a venture capital firm with a major health care investment portfolio, after unexpectedly departing from his position as the country’s top drug regulator this past March.
05/23/2019
The Japanese media reported that Daiichi Sankyo was in talks with several companies to sell its over-the-counter drug unit, Daiichi Sankyo Healthcare, but the company has denied the rumors.
05/22/2019
A group of major pharma companies have teamed up with Verily Life Sciences to overhaul how patients sign up for and engage with clinical trials.
05/22/2019
Amgen has reached an agreement to purchase Copenhagen-based Nuevolution AB for about $167 million.
05/21/2019
The acquisition of Peloton, which was seeking to go public last week, brings its lead kidney cancer drug candidate to Merck, strengthening its renal cell carcinoma presence
05/21/2019
The makers of Acthar gel has filed a lawsuit against the U.S. Department of Health and Human Services following changes to Medicaid rebate calculations
05/20/2019
The U.S. Supreme Court gave Merck & Co. a major victory in a case that could be a milestone for further product liability claims.
05/20/2019
AbbVie is halting a study into a new treatment for glioblastoma.
05/20/2019
Takeda and Frazier Healthcare have announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on novel treatments for gastrointestinal diseases and disorders.
05/20/2019
Sandoz announced a two-stage strategic "transformation" plan, as the company better positions itself for sustainable growth in the generics market.
